Literature DB >> 30285281

Cancer Statistics for Hispanics/Latinos, 2018.

Kimberly D Miller1, Ann Goding Sauer1, Ana P Ortiz2, Stacey A Fedewa3, Paulo S Pinheiro4, Guillermo Tortolero-Luna5, Dinorah Martinez-Tyson6, Ahmedin Jemal7, Rebecca L Siegel8.   

Abstract

Cancer is the leading cause of death among Hispanics/Latinos, who represent the largest racial/ethnic minority group in the United States, accounting for 17.8% (57.5 million) of the total population in the continental United States and Hawaii in 2016. In addition, more than 3 million Hispanic Americans live in the US territory of Puerto Rico. Every 3 years, the American Cancer Society reports on cancer occurrence, risk factors, and screening for Hispanics in the United States based on data from the National Cancer Institute, the North American Association of Central Cancer Registries, and the Centers for Disease Control and Prevention. For the first time, contemporary incidence and mortality rates for Puerto Rico, which has a 99% Hispanic population, are also presented. An estimated 149,100 new cancer cases and 42,700 cancer deaths will occur among Hispanics in the continental United States and Hawaii in 2018. For all cancers combined, Hispanics have 25% lower incidence and 30% lower mortality compared with non-Hispanic whites, although rates of infection-related cancers, such as liver, are up to twice as high in Hispanics. However, these aggregated data mask substantial heterogeneity within the Hispanic population because of variable cancer risk, as exemplified by the substantial differences in the cancer burden between island Puerto Ricans and other US Hispanics. For example, during 2011 to 2015, prostate cancer incidence rates in Puerto Rico (146.6 per 100,000) were 60% higher than those in other US Hispanics combined (91.6 per 100,000) and 44% higher than those in non-Hispanic whites (101.7 per 100,000). Prostate cancer is also the leading cause of cancer death among men in Puerto Rico, accounting for nearly 1 in 6 cancer deaths during 2011-2015, whereas lung cancer is the leading cause of cancer death among other US Hispanic men combined. Variations in cancer risk are driven by differences in exposure to cancer-causing infectious agents and behavioral risk factors as well as the prevalence of screening. Strategies for reducing cancer risk in Hispanic populations include targeted, culturally appropriate interventions for increasing the uptake of preventive services and reducing cancer risk factor prevalence, as well as additional funding for Puerto Rico-specific and subgroup-specific cancer research and surveillance.
© 2018 American Cancer Society.

Entities:  

Keywords:  Hispanics; Latinos; statistics; surveillance

Mesh:

Year:  2018        PMID: 30285281     DOI: 10.3322/caac.21494

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  129 in total

1.  Trends in cause of death among patients with multiple myeloma in Puerto Rico and the United States SEER population, 1987-2013.

Authors:  Maira A Castañeda-Avila; Karen J Ortiz-Ortiz; Carlos R Torres-Cintrón; Brenda M Birmann; Mara M Epstein
Journal:  Int J Cancer       Date:  2019-03-30       Impact factor: 7.396

2.  A culturally and linguistically salient pilot intervention to promote colorectal cancer screening among Latinos receiving care in a Federally Qualified Health Center.

Authors:  Clement K Gwede; Steven K Sutton; Enmanuel A Chavarria; Liliana Gutierrez; Rania Abdulla; Shannon M Christy; Diana Lopez; Julian Sanchez; Cathy D Meade
Journal:  Health Educ Res       Date:  2019-06-01

3.  miR-552 promotes laryngocarcinoma cells proliferation and metastasis by targeting p53 pathway.

Authors:  Jia Gu; Tao Han; Lei Sun; Ai-Hui Yan; Xue-Jun Jiang
Journal:  Cell Cycle       Date:  2020-04-01       Impact factor: 4.534

4.  Disparities Research in Thyroid Cancer: Challenges and Strategies for Improvement.

Authors:  Debbie W Chen; Megan R Haymart
Journal:  Thyroid       Date:  2020-05-21       Impact factor: 6.568

Review 5.  Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving Landscape.

Authors:  Kabir Mody; Ghassan K Abou-Alfa
Journal:  Curr Treat Options Oncol       Date:  2019-01-11

6.  Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants.

Authors:  Priscila Barreto-Coelho; Danielle Cerbon; Matthew Schlumbrecht; Carlos M Parra; Judith Hurley; Sophia H L George
Journal:  Breast Cancer Res Treat       Date:  2019-08-14       Impact factor: 4.872

7.  Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women.

Authors:  Katie M Marker; Valentina A Zavala; Tatiana Vidaurre; Paul C Lott; Jeannie Navarro Vásquez; Sandro Casavilca-Zambrano; Mónica Calderón; Julio E Abugattas; Henry L Gómez; Hugo A Fuentes; Ruddy Liendo Picoaga; Jose M Cotrina; Silvia P Neciosup; Carlos A Castañeda; Zaida Morante; Fernando Valencia; Javier Torres; Magdalena Echeverry; Mabel E Bohórquez; Guadalupe Polanco-Echeverry; Ana P Estrada-Florez; Silvia J Serrano-Gómez; Jenny A Carmona-Valencia; Isabel Alvarado-Cabrero; María Carolina Sanabria-Salas; Alejandro Velez; Jorge Donado; Sikai Song; Daniel Cherry; Lizeth I Tamayo; Scott Huntsman; Donglei Hu; Roberto Ruiz-Cordero; Ronald Balassanian; Elad Ziv; Jovanny Zabaleta; Luis Carvajal-Carmona; Laura Fejerman
Journal:  Cancer Res       Date:  2020-04-03       Impact factor: 12.701

8.  Decídetexto: Mobile cessation support for Latino smokers. Study protocol for a randomized clinical trial.

Authors:  Francisco Cartujano-Barrera; Evelyn Arana-Chicas; Delwyn Catley; Lisa Sanderson Cox; Francisco J Diaz; Edward F Ellerbeck; Kristi D Graves; Chinwe Ogedegbe; Ana Paula Cupertino
Journal:  Contemp Clin Trials       Date:  2020-10-17       Impact factor: 2.226

9.  Increasing access to smoking cessation treatment among Latino smokers using case management.

Authors:  Francisco Cartujano-Barrera; Jaime Perales; Evelyn Arana; Lisa Sanderson Cox; Hung-Wen Yeh; Edward F Ellerbeck; Kimber P Richter; Ana Paula Cupertino
Journal:  J Smok Cessat       Date:  2019-03-11

10.  Validation of plasma metabolites associated with breast cancer risk among Mexican Americans.

Authors:  Hua Zhao; Jie Shen; Yuanqing Ye; Xifeng Wu; Francisco J Esteva; Debasish Tripathy; Wong-Ho Chow
Journal:  Cancer Epidemiol       Date:  2020-09-30       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.